BioSpace News Archive

Expansion of market position through cooperation with established company VWR in the life science sector

BerGenBio ASA announces that the company and its collaborators will present interim clinical and biomarker data from its Phase II clinical programme with bemcentinib (BGB324)

DaVita Kidney Care, a division of DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States, announced the rollout of a new total rewards package, DaVita Rewards, comprising numerous programs and resources to help support teammates inside and outside of work.

Paragonix Technologies, Inc. will present the Paragonix SherpaPak™ Cardiac Transport System product line at Medline Industries, Inc. Booths 45 and 46 during the 2018 American Association of Tissue Banks (AATB) Annual Meeting held in Dallas, TX, from 9 to 12 October, 2018.

Unique Peptide and Liposome Delivery Technology Help Accelerate Body Sculpting Results, Enhance Skin Tightening Treatment Outcomes & Improve Skin Crepiness

Canopy Growth Corporation has completed a legal transfer of cannabis products to a research partner in the United States.

Aurora Cannabis Inc. announced today that the Company has filed an application to list its common shares on the New York Stock Exchange (“NYSE”).

Scientific publication reports preclinical results showing precision oncology opportunity for targeting SHP2 in genetically selected tumors

AVEO Oncology today announced that updated interim data from the Phase 2 portion of the TiNivo trial of tivozanib and nivolumab (OPDIVO®) in advanced renal cell carcinoma will be presented at the European Society of Medical Oncology (ESMO) 2018 Annual Congress being held October 19-23, 2018 in Munich, Germany.

Verastem, Inc. today announced that the National Comprehensive Cancer Network® (NCCN®) added COPIKTRA™ (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).